Pancytopenia as the Initial Presentation of Celiac Disease Authors: Ponn Karthikeyan Saravanamuthu, Anup Kumar Das Published: 2026 ABSTRACT Celiac disease is an immune-mediated enteropathy precipitated by gluten in genetically susceptible individuals. Although diarrhea, weight loss, and malabsorption are classical features, extraintestinal presentations are increasingly recognized. Pancytopenia as the initial manifestation of adult celiac disease is rare and often delays diagnosis. We report a 39-year-old woman from Assam, Northeast India, who presented with chronic diarrhea, weight loss, and progressive weakness, and was found to have severe pancytopenia (hemoglobin 3.9 g/dL, leukocytes 1,200/mm3, and platelets 23,000/mm3). Iron studies suggested iron deficiency. Despite a normal serum vitamin B12 level (874 pg/mL), markedly elevated methylmalonic acid (1,600 nmol/L) and homocysteine (56.8 μmol/L) confirmed functional B12 deficiency. Anti-tissue transglutaminase immunoglobulin A was equivocal, but duodenal biopsy demonstrated partial villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes (Marsh 3A). Peripheral blood flow cytometry was notable for lymphopenia with elevated T-cell receptor αβ+ double-negative T cells (2.59%), a finding of immunological interest. A gluten-free diet with iron, folate, and parenteral B12 supplementation produced rapid clinical and hematological recovery within 3 weeks. At 3-week follow-up, all 3 lineages had improved (hemoglobin 10.4 g/dL, total leukocyte count 3,800/mm3, and platelets 170,000/mm3 by manual count; the platelet count had normalized while hemoglobin and leukocytes were improving but not yet fully normalized). This case underscores celiac disease as a reversible cause of unexplained pancytopenia, highlights the limitations of serum B12 and serology in equivocal presentations, and adds to the limited literature on celiac disease from Northeast India—a region where the condition remains substantially underdiagnosed. INTRODUCTION Celiac disease is a chronic, immune-mediated enteropathy precipitated by gluten ingestion in genetically predisposed individuals.1 While diarrhea, weight loss, and malabsorption represent the classical clinical picture, fewer than half of adults with celiac disease present with predominant gastrointestinal symptoms at diagnosis, and extra-intestinal manifestations are increasingly recognized.2 Hematological abnormalities—most commonly, iron deficiency anemia—are well described, but pancytopenia as the initial manifestation of celiac disease in adults is distinctly uncommon and has been documented mainly in isolated case reports and small series.3 In the Indian subcontinent, the recognized prevalence of celiac disease is highest in the wheat-consuming northern belt; in Northeast India, where rice is the staple cereal, the disease has historically been considered rare and is likely underdiagnosed.4 We report a young woman from Assam in whom severe pancytopenia was the presenting feature of biopsy-confirmed celiac disease, with several instructive features: discordance between normal serum vitamin B12 and markedly elevated metabolic markers, equivocal serology in the presence of unequivocal histology, and a flow cytometric finding of expanded double-negative T cells, which we discuss in the context of the immune dysregulation characteristic of active celiac disease. CASE REPORT A 39-year-old woman presented with a 6-month history of recurrent loose stools, unintentional weight loss, and progressive generalized weakness. There was no history of melena, hematochezia, abdominal pain, fever, or known autoimmune disease. She did not consume alcohol or any regular medication. On examination, she was severely pale with hyperpigmentation over the knuckles. There was no icterus, lymphadenopathy, hepatosplenomegaly, or features of bleeding diathesis. Vital signs were stable. Initial laboratory investigations revealed severe pancytopenia: hemoglobin 3.9 g/dL, total leukocyte count 1,200/mm3, and platelet count 23,000/mm3. The peripheral smear showed a dimorphic picture with predominantly microcytic hypochromic red cells and a reticulocyte count of 1%. Red-cell indices and iron studies were as follows: serum iron 25 μg/dL, serum ferritin 8 ng/mL, total iron-binding capacity 272 μg/dL, mean corpuscular volume 98.2 fL, mean corpuscular hemoglobin 34.9 pg, mean corpuscular hemoglobin concentration 35.6 g/dL, and red cell distribution width 32.6%, consistent with combined iron and macrocytic deficiency. Serum vitamin B12 was 874 pg/mL (within laboratory reference range); however, methylmalonic acid (MMA) was 1,600 nmol/L and homocysteine was 56.8 μmol/L—both markedly elevated—indicating functional vitamin B12 deficiency at the tissue level. Renal function was normal. Total bilirubin was 1.05 mg/dL, serum albumin 2.67 g/dL, and aspartate aminotransferase/alanine aminotransferase/aspartate aminotransferase were 41/33/105 U/L, respectively. Anti-tissue transglutaminase immunoglobulin A (IgA) was equivocal (weakly positive). Reflex serological testing was performed: the IgA endomysial antibody (EMA) was negative (titer 1:10), the deamidated gliadin peptide immunoglobulin G antibody (DGP-IgG) was negative (1.59 U; reference <20), and tissue transglutaminase IgG was only weakly positive (7.30 U/mL; reference <6). A normal total serum IgA excluded selective IgA deficiency as a cause of the low antibody titers, so the overall serological profile was equivocal to negative and the diagnosis rested on characteristic duodenal histology together with the clinical and hematological response to gluten withdrawal. Given the strong clinical suspicion of malabsorption, upper gastrointestinal endoscopy with duodenal biopsy was performed. At endoscopy, the second part of the duodenum showed grossly normal mucosa without scalloping, fissuring, or a nodular or mosaic pattern; the gastric mucosa showed patchy erosive changes. Because a normal endoscopic appearance does not exclude celiac disease, targeted biopsies of the second part of the duodenum were obtained (Figure 1). Histopathology demonstrated partial villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes, consistent with Marsh stage 3A celiac disease (Figure 2). Endoscopic view of the second part of the duodenum showing grossly normal mucosa without scalloping or nodularity. A normal endoscopic appearance does not exclude celiac disease; duodenal biopsy remains essential. Duodenal biopsy (hematoxylin and eosin) demonstrating partial villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes, consistent with Marsh stage 3A celiac disease. (A) Low-power view (original magnification ×100). (B) High-power view (original magnification ×400). Because serology was equivocal, additional investigations were undertaken to evaluate alternative or coexisting causes of villous atrophy. Quantitative immunoglobulins excluded selective IgA deficiency (IgG 17 g/L, IgA 2.13 g/L, immunoglobulin M 0.44 g/L, and immunoglobulin E 348 IU/mL). Peripheral blood flow cytometry showed an absolute lymphocyte count of 825/µL with the following subsets: T cells (cluster of differentiation 3 [CD3]) 665/µL, CD4 413/µL, CD8 175/µL, B cells (CD19) 61/µL, and natural killer cells 78/µL (low-normal). Notably, T-cell receptor (TCR) αβ+ CD4−CD8− double-negative T cells were elevated at 2.59%. Stool routine and culture were unremarkable, barium meal did not demonstrate alternative pathology, and screening for tuberculosis, hepatitis B surface antigen, anti-hepatitis C virus, and HIV antibodies was negative. A bone-marrow aspiration was performed and showed a normocellular, reactive marrow with mild plasmacytosis (approximately 10% polyclonal plasma cells) and no evidence of dysplasia, blast excess, infiltration, or malignancy, effectively excluding a primary marrow disorder. The patient was started on a strict, lifelong gluten-free diet with temporary lactose restriction, oral iron, oral folic acid, and parenteral vitamin B12 supplementation. Two units of packed red cells were transfused for symptomatic anemia, and supportive nutritional counselling was provided. Within 3 weeks, weakness and diarrhea resolved. At 3-week follow-up, all 3 lineages had improved, with hemoglobin rising to 10.4 g/dL, total leukocyte count to 3,800/mm3, and platelet count to 170,000/mm3 (confirmed by manual count, correcting an automated value spuriously lowered by platelet clumping). The platelet count had normalized, while the hemoglobin and leukocyte count, though substantially improved, had not yet fully reached the reference range. Recovery was sustained at approximately 6 months (hemoglobin 10.5 g/dL, total leukocyte count 4,340/mm3, platelets 139,000/mm3). Because 2 units of packed red cells had been transfused, the concurrent recovery of the leukocyte and platelet lines—which are unaffected by red-cell transfusion—provided the more compelling evidence that the cytopenias were attributable to the underlying enteropathy and its nutritional sequelae rather than to a primary marrow disorder. The patient remained clinically well on a sustained gluten-free diet. DISCUSSION This case illustrates 4 clinically important points: (i) celiac disease can present de novo with severe pancytopenia in adults, (ii) a normal serum vitamin B12 level does not exclude tissue-level deficiency, (iii) equivocal serology in the presence of strong clinical suspicion warrants histological evaluation, and (iv) immune dysregulation in active celiac disease can be reflected in peripheral lymphocyte subsets, including expansion of double-negative T cells. The case is also notable as a report from Northeast India, where celiac disease is increasingly recognized but remains substantially underdiagnosed. Pancytopenia as a presenting feature of celiac disease Globally, celiac disease affects approximately 0.7%–1.4% of the population, with serological prevalence higher than biopsy-confirmed prevalence.5 Hematological abnormalities are common,6 but pancytopenia as the initial manifestation is rare. Proposed mechanisms include severe nutritional deficiencies (iron, vitamin B12, folate, and copper), immune-mediated bone marrow suppression, and, in long-standing disease, hypocellular marrow resembling aplastic anemia. In a recent series of 20 pediatric cases, Vajpayee et al3 hypothesized that prolonged immune dysregulation in celiac disease may predispose to bone-marrow failure, with disease duration influencing both presentation and prognosis. In the present case, combined iron deficiency and functional vitamin B12 deficiency, in concert with active mucosal inflammation, are the most plausible contributors to the severity of cytopenias. The prompt, parallel recovery of all 3 lineages after gluten withdrawal and nutrient repletion further argues against a primary hematological disorder and supports a reversible, malabsorption-driven mechanism. Functional vitamin B12 deficiency despite normal serum levels Total serum vitamin B12 reflects both metabolically active and inactive cobalamin fractions and may not accurately represent intracellular bioavailability. MMA and homocysteine are sensitive indicators of tissue-level deficiency: MMA accumulates when methylmalonyl-CoA mutase activity is impaired, and homocysteine rises when methionine synthase activity is reduced.7 Carmel et al7 have shown that elevations of MMA and homocysteine are observed in a meaningful subset of patients with serum B12 levels in the normal range, and that combined biochemical assessment substantially improves diagnostic accuracy compared with serum B12 alone. In our patient, the discordance between a normal serum B12 (874 pg/mL) and markedly elevated MMA (1,600 nmol/L) and homocysteine (56.8 μmol/L) is consistent with this entity and supported the decision to initiate parenteral B12 replacement. Equivocal serology and the role of duodenal biopsy The British Society of Gastroenterology guidelines recommend tissue transglutaminase, EMAs, or DGP-IgA as initial serological tests, with duodenal biopsy retained as the diagnostic gold standard in adults.8 Serology may be equivocal or negative in patients with selective IgA deficiency, those already on a gluten-free diet, in seronegative celiac disease, and in cases with milder mucosal damage. Histological findings indistinguishable from celiac disease can also occur in tropical sprue, postinfectious enteropathy, common variable immunodeficiency, autoimmune enteropathy, nonsteroidal anti-inflammatory drug-induced enteropathy, and food-related enteropathies.9 In our patient, IgA deficiency was excluded, alternative infectious and immunological causes were ruled out, and the combination of compatible clinical phenotype, characteristic Marsh 3A histology, and a rapid response to a gluten-free diet allowed a confident diagnosis. Confirmatory EMA and DGP-IgG serology were negative, and tissue transglutaminase IgG was only weakly positive; accordingly, the diagnosis rested on the combination of a compatible clinical phenotype, characteristic Marsh 3A histology, exclusion of relevant mimics, and an unequivocal response to gluten withdrawal—an approach consistent with guideline provisions for serology-equivocal or seronegative celiac disease. Expanded double-negative T cells: a clue to immune dysregulation An unusual feature in our patient was the expansion of TCRαβ+ CD4−CD8− double-negative (DN) T cells to 2.59% of lymphocytes, against a background of generalized lymphopenia. DN T cells normally constitute less than 1%–1.5% of peripheral T cells; expansion above 1.5%–2.5% is most classically associated with autoimmune lymphoproliferative syndrome but is also reported in systemic lupus erythematosus, Sjögren syndrome, autoimmune hepatitis, and other systemic autoimmune disorders.10 In active celiac disease, Di Sabatino et al11 have demonstrated upregulation of Fas/Fas ligand and increased apoptosis of peripheral lymphocytes, providing a mechanism for the lymphopenia commonly observed in untreated disease. Although the patient did not meet autoimmune lymphoproliferative syndrome criteria (no lymphadenopathy, splenomegaly, or family history), the finding of an elevated DN T-cell fraction in the context of active mucosal inflammation is consistent with the broader pattern of immune dysregulation that characterizes celiac disease and warrants surveillance, particularly given the recognized association of celiac disease with other autoimmune conditions over time. To our knowledge, expansion of double-negative T cells has not been previously highlighted in adult celiac disease presenting with pancytopenia, and this observation may merit further study in larger cohorts. Celiac disease in Northeast India: an under-recognized entity Recognition of celiac disease in India has historically clustered in the wheat-consuming northern belt (Punjab, Haryana, Delhi, and adjoining states), with reported prevalence estimates of approximately 1%–1.2% in screening studies.4 Northeast India—where rice is the dominant staple—was long considered a low-prevalence region, but recent reports from tertiary centers in Assam, Manipur, and adjoining states have increasingly identified biopsy-proven celiac disease, often in patients with atypical or extraintestinal presentations.4 Lower indices of clinical suspicion, limited availability of comprehensive serological panels, and dietary diversification with increased wheat intake all likely contribute to delayed diagnosis. The reports such as ours add to the small but growing body of evidence that celiac disease is not rare in this region and should be actively considered in patients presenting with chronic diarrhea, malabsorption, or otherwise unexplained cytopenias. Management and outcome Hematological abnormalities in celiac disease typically resolve with a strict gluten-free diet and correction of nutritional deficiencies, including iron, folic acid, and parenteral vitamin B12 when indicated. Because secondary brush-border lactase deficiency is common, temporary avoidance of dairy is usually advised. Long-term adherence to a gluten-free diet may itself be associated with subtle B-vitamin deficiencies, and routine use of gluten-free multivitamin supplementation is reasonable in selected patients.12 Early diagnosis avoids unnecessary invasive investigations—such as bone-marrow biopsy—and prevents long-term complications including refractory anemia, osteoporosis, infertility, and, rarely, enteropathy-associated T-cell lymphoma. This report has limitations. Human leukocyte antigen-DQ2/DQ8 genotyping and follow-up serology on a gluten-free diet were not performed, and the duration of follow-up was short; longer observation would be required to document full and sustained hematological normalization. Nonetheless, the characteristic histology, exclusion of alternative causes, and prompt clinical and hematological response to gluten withdrawal together support the diagnosis. DISCLOSURES Author contributions: PK Saravanamuthu: conceptualization, clinical care of the patient, literature review, data collection, manuscript drafting, and submission. AK Das: clinical supervision, critical revision of the manuscript for important intellectual content, and final approval of the submitted version. P.K. Saravanamuthu is the article guarantor. Financial disclosure: None to report. Previous Presentation: This case was presented as a poster at the Assam Association of Physicians of India—Assam Chapter Annual Conference, December 2025; Kaziranga, Assam, India. AI disclosure: Anthropic Claude (claude.ai) was used to assist with language editing and manuscript structuring. All clinical content, data, interpretations, and references were verified by the authors, who accept full responsibility for the accuracy and integrity of the work. Informed consent was obtained for this case report.